Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a US biotechnology company specializing in molecular glue degraders. These small molecules trigger the targeted destruction of disease-causing proteins, with a focus on oncology and immune-mediated diseases.
Frequently asked questions
When will Monte Rosa Therapeutics report its next quarterly earnings?
Monte Rosa Therapeutics is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Monte Rosa Therapeutics last report quarterly earnings?
Monte Rosa Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.43 USD.
How often has Monte Rosa Therapeutics beaten expectations?
Monte Rosa Therapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Monte Rosa Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
-16.4%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Monte Rosa Therapeutics
Country
🇺🇸
More Financial Information